摘要
Background: Red yeast rice (RYR), a nutraceutical with a profound cholesterol-lowering effect, was found to attenuate non-alcoholic fatty liver disease (NAFLD) in mice. Despite monacolin K in RYR being a specific inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMCGR), the mechanisms underlying the protective effects of RYR against NAFLD are not fully elucidated. @@@ Methods: Using a mouse model of high-fat diet (HFD) feeding and a cellular model of HepG2 cells challenged by lipopolysaccharide (LPS) and palmitic acid (PA), the possible molecular mechanisms were exploited in the aspects of NF-kappa B/NLRP3 inflammasome and mTORC1-SREBPs signaling pathways by examining the relevant gene/protein expressions. Subsequently, the correlation between these two signals was also verified using cellular experiments. @@@ Results: RYR ameliorated lipid accumulation and hepatic inflammation in vivo and in vitro. RYR improved lipid metabolism through modulating mTORC1-SREBPs and their target genes related to triglyceride and cholesterol synthesis. Furthermore, RYR suppressed hepatic inflammation by inhibiting the NF-kappa B/NLRP3 inflammasome signaling. Interestingly, the treatment with RYR or MCC950, a specific NLRP3 inhibitor, resulted in the reduced lipid accumulation in HepG2 cells challenged by LPS plus PA, suggesting that the inhibitory effects of RYR on NLRP3 inflammasome-mediated hepatic inflammation may partially, in turn, contribute to the lipid-lowering effect of RYR. @@@ Conclusions: The modulation of NF-kappa B/NLRP3 inflammasome and lipid synthesis may contribute to the ameliorative effects of RYR against HFD-induced NAFLD.
学科与关键词
- NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD miceWang, Xianfei; Sun, Kangyue; Zhou, Youlian; Wang, Hong; Zhou, Yongjian; Liu, Side; Nie, Yuqiang*; Li, Yue*Biochemical and Biophysical Research Communications, 2021, 534: 734-739.被引 28
- Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob miceMeng, Ling-Cui; Zheng, Jia-Yi; Qiu, Yu-Hui; Zheng, Li; Zheng, Jue-Yan; Liu, Yu-Qing; Miao, Xiao-Lu*; Lu, Xin-Yi*International Immunopharmacology, 2022, 111: 109099.被引 9
- Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-ΚB/NLRP3 signaling pathwayDeng, Yan-fang; Xu, Qian-qian; Chen, Tian-qi; Ming, Jia-xiong; Wang, Ya-fen; Mao, Li-na; Zhou, Jia-jun; Sun, Wei-guang*; Zhou, Qun*; Ren, Hong*; Zhang, Yong-hui*PHYTOMEDICINE, 2022, 104: 154241.被引 13
